Scientists have identified a protein which is associated with more aggressive breast, colorectal and ovarian cancers, which could be used to assist the diagnosis and development treatments for these cancers.

Some bowel cancers that are resistant to treatment could be re-sensitised using drugs that reduce inflammation, according to new research.

Bowel cancer patient and fundraiser Tim Morgan and founder of The Chris Lucas Trust, Lynn Lucas, were thanked at the October meeting of the ICR's Discovery Club for their phenomenal fundraising efforts to support our research.